» Articles » PMID: 22460595

Bioavailability and in Vivo Efficacy of a Praziquantel-polyvinylpyrrolidone Solid Dispersion in Schistosoma Mansoni-infected Mice

Overview
Date 2012 Mar 31
PMID 22460595
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

One of the problems of praziquantel (PZQ) is its very low aqueous solubility. Moreover, its dissolution rate is considered the limiting factor for its bioavailability. This work correlates the physical properties and the dissolution behavior of PZQ-polyvinylpyrrolidone (PVP) solid dispersion (SD) at the ratios of 1:1 and 3:7 with its oral bioavailability and its in vivo efficacy against Schistosoma mansoni (S. mansoni). The PZQ and PZQ-PVP SD were characterized by infrared spectroscopy, differential scanning calorimetry, scanning electron microscopy (SEM) and solubility test. Results showed a decrease in crystallinity, possible interaction between PZQ and PVP, greater increase in dissolution rate and appreciable reduction in particle size. S. mansoni-infected mice treated orally with either pure PZQ or PZQ-PVP at a single dose of 500 mg/kg showed a higher increase in AUC((0-8h)), C (max), K(a) and t (1/2e) with a significant decrease in k (el) versus the corresponding uninfected mice. Moreover, uninfected and infected mice treated with PZQ-PVP SD showed 2.3-, 1.6- and 1.3-, 1.25-fold increase, respectively, in AUC((0-8h)) and C(max), with a decrease in k(el) and increase in t (1/2e) by twofold versus the corresponding pure PZQ-treated groups. Percentage worm reduction at all administered doses (62.5, 125, 250, 500 and 1,000 mg/kg) was significantly higher (1- to 1.5-fold) in mice treated with PZQ-PVP SD (ED₅₀ = 40.92) versus those treated with pure PZQ (ED₅₀ = 99.29). In addition, a significant reduction in total tissue egg load concomitant with a significant decrease in total immature and mature eggs and an increase in dead eggs in PZQ-PVP SD-treated groups versus their corresponding pure PZQ-treated groups was recorded. Solid dispersion of PZQ with PVP could lead to a further improvement in the effectiveness of PZQ therapy especially with the appearance of some PZQ-tolerant S. mansoni isolates.

Citing Articles

-Schistosomal activity and ADMET properties of 1,2,5-oxadiazinane-containing compound synthesized by visible-light photoredox catalysis.

Itoh K, Nakahara H, Takashino A, Hara A, Katsuno A, Abe Y RSC Med Chem. 2024; .

PMID: 39399310 PMC: 11467761. DOI: 10.1039/d4md00599f.


Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel.

Polyzois H, Nguyen H, Roberto de Alvarenga Junior B, Taylor L Mol Pharm. 2024; 21(10):5285-5296.

PMID: 39292641 PMC: 11462518. DOI: 10.1021/acs.molpharmaceut.4c00711.


Praziquantel Fifty Years on: A Comprehensive Overview of Its Solid State.

DAbbrunzo I, Procida G, Perissutti B Pharmaceutics. 2024; 16(1).

PMID: 38258039 PMC: 10821272. DOI: 10.3390/pharmaceutics16010027.


Revisiting the Dissolution of Praziquantel in Biorelevant Media and the Impact of Digestion of Milk on Drug Dissolution.

Eason T, Ramirez G, Clulow A, Salim M, Boyd B Pharmaceutics. 2022; 14(10).

PMID: 36297662 PMC: 9609124. DOI: 10.3390/pharmaceutics14102228.


Tunable Polymeric Mixed Micellar Nanoassemblies of Lutrol F127/Gelucire 44/14 for Oral Delivery of Praziquantel: A Promising Nanovector against in Experimentally-Infected Rats.

Arafa W, Elkomy M, Aboud H, Ali M, Abdel Gawad S, Aboelhadid S Pharmaceutics. 2022; 14(10).

PMID: 36297459 PMC: 9608995. DOI: 10.3390/pharmaceutics14102023.


References
1.
Xiao S, Catto B, WEBSTER Jr L . Quantitative determination of praziquantel in serum by high-performance liquid chromatography. J Chromatogr. 1983; 275(1):127-32. DOI: 10.1016/s0378-4347(00)84351-0. View

2.
Chiou W, RIEGELMAN S . Pharmaceutical applications of solid dispersion systems. J Pharm Sci. 1971; 60(9):1281-302. DOI: 10.1002/jps.2600600902. View

3.
Pellegrino J, Oliveira C, Faria J, Cunha A . New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am J Trop Med Hyg. 1962; 11:201-15. DOI: 10.4269/ajtmh.1962.11.201. View

4.
Hasegawa S, Hamaura T, Furuyama N, Kusai A, Yonemochi E, Terada K . Effects of water content in physical mixture and heating temperature on crystallinity of troglitazone-PVP K30 solid dispersions prepared by closed melting method. Int J Pharm. 2005; 302(1-2):103-12. DOI: 10.1016/j.ijpharm.2005.06.021. View

5.
CHEEVER A . Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. Bull World Health Organ. 1968; 39(2):328-31. PMC: 2554554. View